Update History
Syndrome: Acute Intermittent Porphyria
Gene/Gene Panel: HMBS
Updated By
Date
Status
Outcome-Interventions
Notes
Genboree Administrator Account
2018/11/01
Released
1.0.4
Hepatocellular carcinoma
Liver US surveillance 10CC
Morbidity of acute attacks
Optimal treatment (Hemin) in the event of an attack 10CB
Neurovisceral attacks
Optimal clinical management to reduce risk of attacks (e.g., avoidance of harmful medications, dietary advice, treatment of infections, avoidance of smoking/alcohol) 9CB
Internal system migration related to score text replacement from E to N
Elizabeth Clarke
2018/02/15
Released
1.0.3
Hepatocellular carcinoma
Liver US surveillance 10CC
Morbidity of acute attacks
Optimal treatment (Hemin) in the event of an attack 10CB
Neurovisceral attacks
Optimal clinical management to reduce risk of attacks (e.g., avoidance of harmful medications, dietary advice, treatment of infections, avoidance of smoking/alcohol) 9CB
Kathleen Mittendorf
2018/01/11
Released
1.0.2
Hepatocellular carcinoma
Liver US surveillance 10CC
Morbidity of acute attacks
Optimal treatment (Hemin) in the event of an attack 10CB
Neurovisceral attacks
Optimal clinical management to reduce risk of attacks (e.g., avoidance of harmful medications, dietary advice, treatment of infections, avoidance of smoking/alcohol) 9CB
Elizabeth Clarke
2017/10/23
Released
1.0.1
Hepatocellular carcinoma
Liver US surveillance 10CC
Morbidity of acute attacks
Optimal treatment (Hemin) in the event of an attack 10CB
Neurovisceral attacks
Optimal clinical management to reduce risk of attacks (e.g., avoidance of harmful medications, dietary advice, treatment of infections, avoidance of smoking/alcohol) 9CB
¤ Powered by BCM's Genboree.